Def Pen
  • News
    • World
    • US
    • Politics
  • Music
    • News
    • Hip Hop
    • R&B
    • Pop
    • First To The Aux
  • Sports
    • Basketball
      • NBA
      • WNBA
      • NCAAB
      • EuroLeague
      • High School
    • Football
      • NFL
      • XFL
      • NCAAF
    • Baseball
      • MLB
    • MMA
    • Boxing
    • FIFA
    • Sports Betting
    • Track & Field
  • Fashion
  • Business
  • Movies
    • Trailers
  • TV
  • Tech
  • Women
    • Spotlight On Empowerment
  • Shop
Def Pen
  • News
    • World
    • US
    • Politics
  • Music
    • News
    • Hip Hop
    • R&B
    • Pop
    • First To The Aux
  • Sports
    • Basketball
      • NBA
      • WNBA
      • NCAAB
      • EuroLeague
      • High School
    • Football
      • NFL
      • XFL
      • NCAAF
    • Baseball
      • MLB
    • MMA
    • Boxing
    • FIFA
    • Sports Betting
    • Track & Field
  • Fashion
  • Business
  • Movies
    • Trailers
  • TV
  • Tech
  • Women
    • Spotlight On Empowerment
  • Shop
  • News
  • US

First Round Of Moderna COVID-19 Vaccines Ship After FDA Aprroval

  • December 21, 2020
  • Ryan Shepard
The Moderna campus seen in Norwood, Massachusetts on on December 2, 2020, where the biotechnology company is mass producing its Covid-19 vaccine. – The US hopes to have immunized 100 million people against Covid-19 by the end of February, a top official said on December 2, which is approximately 40 percent of the country’s adult population. The push should start within weeks, when vaccines developed by Pfizer-BioNTech and Moderna-NIH are expected to be approved. (Photo by JOSEPH PREZIOSO/AFP via Getty Images)

The first round of Moderna COVID-19 vaccines has shipped out after approval from the Food and Drug Administration. With the help of healthcare company McKesson, the pharmaceutical company will begin distributing the vaccine across the map this week. FedEx and UPS trucks containing the vaccine were reportedly spotted in Mississippi and Kentucky on Sunday. In addition, Moderna is also supply medical professionals with kits of supplies needed to apply the vaccine.

“[I am] honored to be a partner with the U.S. government and other private-sector companies such as Moderna to support in the distribution of COVID-19 vaccines and the ancillary supply kits,” McKesson CEO Brian Tyler said.

Moderna’s vaccine follows closely behind the release date of Pfizer and BioNTech’s vaccine. Initial reports suggest that the Moderna vaccine was 95% effective for the general population during clinical trials. However, further reports indicated that the vaccine was only 85% effective for those over 65 years of age.

Expect the vaccine to be doled out to medical professionals and elderly Americans later this week.

 

 

Related Topics
  • Brian Tyler
  • Coronavirus
  • COVID-19
  • Moderna
Ryan Shepard

You May Also Like
View Article
  • Hip Hop
  • Music
  • News
  • US

United Sates vs. Sean ‘Diddy’ Combs: Jury Expected To Be Seated Wednesday

  • Ryan Shepard
  • May 7, 2025
View Article
  • Music
  • News
  • US

United Sates vs. Sean ‘Diddy’ Combs: Diddy Rejects Plea Deal, Says Federal Prosecutor

  • Ryan Shepard
  • April 27, 2025
View Article
  • News
  • Politics
  • US

Several Democrats Plan To Skip Donald Trump’s Joint Address

  • Ryan Shepard
  • March 4, 2025
View Article
  • News
  • Politics
  • US

Sen. Elissa Slotkin To Deliver Democratic Party’s Response To Trump’s Joint Address

  • Ryan Shepard
  • March 4, 2025
View Article
  • News
  • Politics
  • US

Trudeau Opposes Call To Ban Trump From G7 Summit

  • Ryan Shepard
  • March 1, 2025
View Article
  • News
  • Politics
  • World

Human Rights Groups Worry Central America Could Become ‘Black Hole’ For Migrants

  • Ryan Shepard
  • March 1, 2025
View Article
  • News
  • Politics
  • US

State Department Terminates USAID Program Providing Support For Ukraine’s Power Grid

  • Ryan Shepard
  • March 1, 2025
View Article
  • News
  • Politics
  • World

Trump, Zelenskyy Meeting Goes Off The Rails

  • Ryan Shepard
  • February 28, 2025

©Copyright 2024 DefPen.com. All rights reserved.

Def Pen is a registered trademark. DefPen.com is part of the Def Pen Media Group, LLC.

  • Contact
  • Advertising
  • Privacy Policy
  • DMCA
  • Shop

Input your search keywords and press Enter.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT